Clinical Trials Browser

Phase 3 × BCG Vaccine × 90 days × Clear all

NCT05538663 2026-05-05

BRIDGE

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT03711032 2026-05-01

MK-3475-676

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT03528694 2026-04-14

POTOMAC

Phase 3 Active not recruiting

1,018 enrolled 1 FDA

Non-Muscle Invasive Bladder Neoplasms

NCT05037279 2026-03-20

EVER

Phase 3 Recruiting

Urinary Bladder Neoplasms, Recurrence